FDA Inspection 1048701 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on Jan 9, 2018 in Pompano Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 9, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pompano Beach, FL (United States)